Table 3.
Predictors for the ischaemic stroke vs intracranial haemorrhage in coronary artery disease patients in multivariate model.
| Ischaemic stroke | Intracranial haemorrhage | |||||||||||
| Univariate | multivariate | univariate | multivariate | |||||||||
| HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | HR | 95% CI | P value | |
| Age, years | 1.05 | 1.02-1.08 | .00 | 1.03 | 0.99–1.07 | 0.08 | 1.09 | 1.02–1.16 | .008 | 1.07 | 1.00–1.14 | .04 |
| Fasting glucose, mg/dL | 1.00 | 1.00–1.01 | .03 | 1.00 | 0.99–1.01 | 0.13 | ||||||
| Creatinine, mg/dL | 1.22 | 0.76–1.21 | .01 | 0.95 | 0.73–1.25 | 0.73 | ||||||
| eGFR, mL/min/1.73m2 | 0.98 | 0.96–0.99 | .00 | 0.98 | 0.96–1.00 | 0.07 | ||||||
| Hgb, mg/dL | 0.79 | 0.67–0.95 | .01 | 0.99 | 0.81–1.24 | 0.99 | ||||||
| ACEI, n (%) | 1.89 | 0.91–3.91 | .08 | 1.92 | 0.87–4.25 | .11 | ||||||
| Statin, n (%) | 0.42 | 0.21–0.85 | .01 | 0.37 | 0.17–0.79 | .01 | ||||||
| BNP, mg/dL | 1.00 | 1.00–1.00 | .07 | 1.03 | 0.94–1.13 | .46 | ||||||
| NT-proBNP, mg/dL | 1.00 | 1.00–1.00 | .01 | 1.02 | 0.97–1.06 | .37 | ||||||
| FABP3, ng/mL | 1.00 | 1.00–1.00 | .03 | 1.00 | 0.99–1.00 | .62 | ||||||
| Myeloperoxidase, ng/mL | 3.42 | 1.48–7.91 | .00 | 1.89 | 1.16–3.10 | .01 | ||||||
| NGAL, ng/mL | 1.00 | 1.00–1.00 | .07 | 1.00 | 1.00–1.00 | .77 | ||||||
| ARB, n (%) | 10.03 | 1.25–80.1 | .03 | 9.11 | 1.14–72.9 | .03 | ||||||
| nitrate, n (%) | 4.49 | 0.93–21.6 | .06 | 3.32 | 0.67–16.4 | .14 | ||||||
| CXCL16, pg/mL | 1.00 | .099–1.00 | .09 | 0.05 | 0.00–4.71 | .19 | ||||||